According to a new report Global Genetic Testing Market, published by KBV research, The Global Genetic Testing Market size is expected to reach $16.9 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period.
The North America market dominated the Global Predictive and Presymptomatic Testing Market by Region in 2018, growing at a CAGR of 11.8 % during the forecast period. The Europe market is expected to witness a CAGR of 12% during (2019 - 2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 13.9% during (2019 - 2025).
The Molecular Testing market dominated the Global Genetic Testing Market by Technology in 2018, growing at a CAGR of 11 % during the forecast period. The Biochemical Testing market is expected to witness a CAGR of 11.7% during (2019 - 2025).
The Genetic Disease Diagnosis market dominated the Global Genetic Testing Market by Application in 2018, growing at a CAGR of 10.7 % during the forecast period. The Cancer Diagnosis market is expected to witness a CAGR of 10.7% during (2019 - 2025).
Full Report:https://www.kbvresearch.com/genetic-testing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).
By Type
By Technology
By Application
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
